(Health-NewsWire.Net, September 12, 2019 ) Market Overview: Tuberculosis (TB), known as poor man’s disease, is caused by Mycobacterium tuberculosis germs that are spread from person to person through the air. TB usually affects the lungs and affects the other parts of the body such as the brain, the kidneys, or the spine. Across the globe, almost two billion people are infected with M. tuberculosis.
Market Dynamics: The primary factors driving the Tuberculosis Drug market have increased the incidence of TB in Africa and Asia, Emergence of MDR-TB and XDR-TB strains and Increase in an outbreak of TB-HIV co-infection.The high prevalence of TB in Asia and Africa is driving the TB drug market.
Market Segmentation: By Therapy Type • First Line Drugs Therapy • Second Line Drugs Therapy • Combination Drugs Therapy
By Type • Latent TB Type • Active Type
Geographical Analysis: By Geography, the market is segmented into: • North America • Europe • South America • Asia Pacific • The Middle East and Africa
About Us DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information: Sai Kiran Sales Manager at Data M Intelligence Email: info@datamintelligence.com Tel: +1 877 441 4866 Website: www.datamintelligence.com
